Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 4/20 | 0.43 |
| ▸ | NPC1 | O15118 | 3/20 | 0.43 |
| ▸ | RAB9A | P51151 | 3/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 5/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | CASP3 | P42574 | 1/20 | 0.42 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.42 |
| ▸ | RELA | Q04206 | 1/20 | 0.42 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.42 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.42 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10111192 | 1.00 | MAPT (0.43) | MAPTNPC1RAB9ASMN1; SMN2MEN1 | |
| SCHEMBL27128218 | 0.91 | CES2 (0.46) | MAPTCES2CES1CA1CA2 | |
| SCHEMBL17223079 | 0.91 | CES2 (0.46) | MAPTCES2CES1CA1CA2 | |
| SCHEMBL17223080 | 0.91 | CES2 (0.46) | MAPTCES2CES1CA1CA2 | |
| SCHEMBL459783 | 0.86 | ATM (0.42) | MAPTSMN1; SMN2MEN1KMT2ACYP3A4 | |
| SCHEMBL459784 | 0.86 | ATM (0.42) | MAPTSMN1; SMN2MEN1KMT2ACYP3A4 | |
| SCHEMBL17456643 | 0.80 | NPC1 (0.50) | MAPTNPC1RAB9ASMN1; SMN2MEN1 | |
| SCHEMBL17470407 | 0.80 | NPC1 (0.50) | MAPTNPC1RAB9ASMN1; SMN2MEN1 | |
| SCHEMBL11673953 | 0.79 | MEN1 (0.47) | MAPTNPC1RAB9ASMN1; SMN2MEN1 | |
| SCHEMBL18327183 | 0.77 | MAPT (0.41) | MAPTNPC1RAB9ASMN1; SMN2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10790451-B2 | Triazole derivative, and light-emitting element, light-emitting device, and electronic device with the use of triazole derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2020-09-29 | — | — | US | disclosed |
| CN-110724124-A | Triazole derivatives | 株式会社半导体能源研究所 | 2020-01-24 | — | — | CN | disclosed |
| US-20160268515-A1 | TRIAZOLE DERIVATIVE, AND LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, AND ELECTRONIC DEVICE WITH THE USE OF TRIAZOLE DERIVATIVE | SEMICONDUCTOR ENERGY LAB (JP) | 2016-09-15 | — | — | US | disclosed |
| US-8592056-B2 | Triazole derivative, and light-emitting element, light-emitting device, and electronic device with the use of triazole derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2013-11-26 | — | — | US | disclosed |
| US-20120199818-A1 | TRIAZOLE DERIVATIVE, AND LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, AND ELECTRONIC DEVICE WITH THE USE OF TRIAZOLE DERIVATIVE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2012-08-09 | — | — | US | disclosed |
| US-8178217-B2 | 4-(4-bromophenyl)-3,5-diphenyl-4H-1,2,4-triazole; high triplet excitation energy; high luminous efficiency, low power consumption | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2012-05-15 | — | — | US | disclosed |
| WO-2008143019-A1 | TRIAZOLE DERIVATIVE, AND LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, AND ELECTRONIC DEVICE WITH THE USE OF TRIAZOLE DERIVATIVE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2008-11-27 | — | — | WO | disclosed |
| US-20080286607-A1 | Triazole derivative, and light-emitting device, and electronic device with the use of triazole derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2008-11-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120199818-A1 | TRIAZOLE DERIVATIVE, AND LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, AND ELECTRONIC DEVICE WITH THE USE OF TRIAZOLE DERIVATIVE | TYR, TH, YEATS4 | MAPT 2450/4885NPC1 4496/4885RAB9A 2385/4885 |
| US-20160268515-A1 | TRIAZOLE DERIVATIVE, AND LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, AND ELECTRONIC DEVICE WITH THE USE OF TRIAZOLE DERIVATIVE | TYR, TH, YEATS4 | MAPT 2450/4885NPC1 4496/4885RAB9A 2385/4885 |
| US-10790451-B2 | Triazole derivative, and light-emitting element, light-emitting device, and electronic device with the use of triazole derivative | TYR, TH, YEATS4 | MAPT 2450/4885NPC1 4496/4885RAB9A 2385/4885 |
| US-20080286607-A1 | Triazole derivative, and light-emitting device, and electronic device with the use of triazole derivative | TYR, TH, CYP3A4 | MAPT 2676/4885NPC1 4624/4885RAB9A 2455/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.